HHS officials had a briefing from Pfizer on Monday regarding their latest, preliminary data on vaccinations and will continue to discuss when and if booster shots will be needed in the future, the spokesperson said.

Pfizer said it planned to publish “more definitive data” in a peer-reviewed journal.